Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03777657
Title Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma


Capecitabine + Oxaliplatin

Cisplatin + Fluorouracil

Capecitabine + Oxaliplatin + Tislelizumab

Cisplatin + Fluorouracil + Tislelizumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.